Return to previous pagePrint page
Class of 2023
Session Information


Go Back Go Back
Session Title:
Approach to Tuberculosis
Teaching Hours:
Teaching and Learning MethodsTotal Scheduled Hours = 2
Lecture = 2
Description:
Combines approaches of infectious diseases, respiratory and pathology to tuberculosis.
Keywords:
Teaching and Learning Methods
Lecture 2 hour(s)

Learning Objectives
Blueprint ID Learning Objectives
9514 Define Gohn focus and Gohn complex
9515 Describe the role of the immune system response to the mycobacterium tuberculosis hominis in the development of: (a) the natural history of tuberculosis (progression versus healing), (b) the evolution of 1° to 2° tuberculosis, and (c) the typical histologic findings in tuberculosis
9516 Describe the gross patterns and consequent impact on the patient of the following patterns of tuberculosis: (a) 1° Tuberculosis, (b) 2° Tuberculosis, (c) Miliary Tuberculosis
9517 Describe the pathogenesis of tuberculosis including how the organism enters and is disseminated in the body and why and how granulomas form.
11812 Describe the stages and risk of progression of Tuberculosis.
11813 Describe risk factors (likelihood) for Tuberculosis infection and disease.
11814 Describe global and national epidemiology in reference to incidence, mortality, and the measurement of burden.
11815 Describe multi-drug resistant and extensively drug resistant Tuberculosis including geographic locations of drug resistance.
11816 Describe current and developmental vaccination for Tuberculosis.
11817 Describe public health interventions for Tuberculosis including active and passive screening.
11818 Describe the chest X-ray patterns in latent and active Tuberculosis.
11819 Describe the treatment of latent Tuberculosis including: first line regimens; toxicity; decision to treat; reduction in risk of activation due to treatment; and LTBI treatment as control measure.
11820 Describe the treatment of active Tuberculosis including first line regimen.
11821 Describe directly observed therapy for Tuberculosis.
11822 Describe toxicity associated with Tuberculosis treatments.
11823 Describe testing during treatment of Tuberculosis.
11824 Describe duration and reasons for extending duration of treatment for Tuberculosis.

Linked Course Goal(s) to Session
Blueprint ID Course Goals
7426 Identify a strategy for monitoring health problems over time
Linked Program Competencies
To This Course Goal:
me-4 me-5 cm-1 cm-2 cm-3 cm-4 cm-5 cm-6 co-1 co-2 co-3 co-4 ld-3 ha-1
7427 Identify the ongoing supports needed by patients with chronic disease
Linked Program Competencies
To This Course Goal:
me-4 me-5 cm-2 cm-4 cm-5 cm-6 co-1 co-2 co-3 co-4 ha-1 ha-2 ha-3
7443 Develop a patient care plan in cooperation with other health care providers
Linked Program Competencies
To This Course Goal:
cm-4 cm-5 co-1 co-2 co-3 co-4
7452 Identify available health care resources in the investigation, treatment and ongoing management of the patient
Linked Program Competencies
To This Course Goal:
me-4 me-5 co-2 ld-2 ld-3 ha-3
9893 Identify and diagnose key clinical problems
Linked Program Competencies
To This Course Goal:
me-1 me-2 me-3 me-4 me-5 me-6
Linked Program Competencies To Course Goal(s)
me-4 Medical Expert
Develop a differential diagnosis and key clinical problem list following assessment of a patient.
me-5 Medical Expert
Develop a management plan for key clinical problems following assessment of a patient.
cm-1 Communicator
Develop and maintain appropriate ethical and therapeutic relationships, rapport and trust with patients and their families.
cm-2 Communicator
Collect and synthesize accurate and relevant information, incorporating perspectives from patients and their families, colleagues and other health care professionals.
cm-3 Communicator
Discuss relevant health care information and management plans with patients and their families.
cm-4 Communicator
Develop a shared plan of care with patients, their families, and other health care professionals.
cm-5 Communicator
Demonstrate effective oral and written communication of information associated with a medical encounter.
cm-6 Communicator
Discuss effective strategies for communicating with third parties other than health care professionals.
co-1 Collaborator
Demonstrate effective collaboration skills within the health care system.
co-2 Collaborator
Demonstrate effective consultation with other health care professionals to provide care for individuals, communities, and populations.
co-3 Collaborator
Demonstrate respect for health care team members without bias (e.g., bias related to gender, ethnicity, cultural background or health care role).
co-4 Collaborator
Demonstrate effective strategies to promote understanding, manage differences and resolve conflicts through negotiation and collaboration.
ld-3 Leader
Describe the roles and responsibilities of physicians and governing bodies in the development and support of the health care system.
ha-1 Health Advocate
Identify the important determinants of health, risk factors for illness, interaction between the population and their physical, biological and social environment, and personal attributes.
ha-2 Health Advocate
Identify public policies and trends that affect health locally, nationally, and globally, and barriers to access for populations, including persons with disabilities, the underserved and the marginalized.
ha-3 Health Advocate
Assess and respond to issues in the Canadian health care system and advocate for patients at all levels.
ld-2 Leader
Apply evidence and management processes to effectively allocate health care resources.
me-1 Medical Expert
Perform a complete and accurate patient-centred history appropriate to the patient’s presentation.
me-2 Medical Expert
Perform a complete and accurate physical examination appropriate to the patient’s presentation.
me-3 Medical Expert
Formulate an initial plan of appropriate diagnostic and therapeutic procedures relevant to the patient’s presentation.
me-6 Medical Expert
Apply knowledge of the clinical, socio-behavioural, and fundamental biomedical sciences relevant to a clinical problem.

Linked MCC Medical Expert Objectives
(007) BLOOD IN SPUTUM (HEMOPTYSIS)
icon
(018) COUGH
icon
(027) DYSPNEA
icon
(107-4) FEVER IN THE IMMUNE COMPROMISED HOST / RECURRENT FEVER
icon
(107-1) FEVER AND HYPERTHERMIA
icon
(074-2) IMMUNIZATION
icon
(054) LYMPHADENOPATHY
icon
(076) PLEURAL EFFUSION
icon
(078-6) ENVIRONMENT
icon
(078-3) INTERVENTIONS AT THE POPULATION LEVEL
icon
(127) PROVIDING ANTI-OPPRESSIVE HEALTH CARE
icon